Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VALIDE: Enoxaparin Dose Adaptation in Moderate Renal Failure and ACS
NCT00412802Phase 4Completed
- Sponsor
- Société Française de Cardiologie
- Start
- Dec 2006
- Primary completion
- Mar 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of enoxaparin in acute coronary syndrome (ACS), sponsored by Société Française de Cardiologie. Started Dec 2006; status: completed.
02
Drugs
enoxaparin
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT00412802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00412802.